| Medical practice confirms clinical trial results of the use of intralesional human recombinant epidermal growth factor in advanced diabetic foot ulcers PA López-Saura, IB Yera-Alos, C Valenzuela-Silva, O González-Díaz, ... Adv Pharmacoepidem Drug Safety 2 (2), 128, 2013 | 35 | 2013 |
| Under reporting of ADRs by medical practitioners in India—results of pilot study RK Rishi, RK Patel, A Bhandari Adv Pharmacoepidem Drug Saf 1 (3), 112, 2012 | 33 | 2012 |
| Adverse events in HIV-infected children on antiretroviral therapy at a teaching hospital in Lagos, Nigeria: a retrospective study KA Oshikoya, S Lawal, IA Oreagba, O Awodele, SO Olayemi, E Iroha Adv Pharmacoepidem Drug Safety 1 (4), 1000117, 2012 | 31 | 2012 |
| Perceptions of doctors and pharmacists towards medication error reporting and prevention in Kedah, Malaysia: a Rasch model analysis B Teoh, A Alrasheedy, M Hassali, M Tew, M Samsudin Adv Pharmacoepidemiol Drug Saf 4 (192), 1052-2167, 2015 | 28 | 2015 |
| National Drug Information Center Services through Ministry of Health Hotline Calling Center (937) in Saudi Arabia YA Alomi, HA Mudaiheem, A Alsharfa, H Albassri, K Alonizi Adv Pharmacoepidemiol Drug Saf 5 (1), 1-7, 2016 | 27 | 2016 |
| Assessment of knowledge, attitude and practices of adverse drug reaction reporting among doctors and pharmacists in primary healthcare MM Tew, BC Teoh, AS Mohd Baidi, HL Saw Adv Pharmacoepidemiol Drug Saf 5 (206), 2167-1052.1000206, 2016 | 24 | 2016 |
| Safety and tolerability of EPs 7630 in clinical trials H Matthys, S Köhler, W Kamin Adv Pharmacoepidemiol Drug Saf 2 (04), 142, 2013 | 23 | 2013 |
| Pharmacovigilance of herbal medicine: Herbavigilance HZ Toklu Adv Pharmacoepidemiol Drug Saf 5 (208), 2167-1052.1000208, 2016 | 20 | 2016 |
| Prevalence, determinants, and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan T Obara, H Yamaguchi, M Satoh, Y Iida Advances in Pharmacoepidemiology & Drug Safety 4 (05), 2015 | 20 | 2015 |
| Indian Pharmacopoeia commission's partners for promoting public health V Kalaiselvan, R Kumar, GN Singh Adv Pharmacoepidemiol Drug Saf 4 (181), 2167-1052, 2015 | 19 | 2015 |
| Direct consumer reporting of ADRs to PvPI, a position paper of Indian pharmacopoeia commission M Kalaivani, V Kalaiselvan, K Dabhi, GN Singh Adv Pharmacoepidemiol Drug Saf 4 (184), 2167-1052.1000184, 2015 | 18 | 2015 |
| Estimating the prevalence and the determinants of polypharmacy using data from a health administrative database: a comparison of results obtained employing different algorithms V Fano, F Chini, P Pezzotti, K Bontempi Adv Pharmacoepidemiol Drug Saf 3 (151), 2167-1052, 2014 | 17 | 2014 |
| The potential effect of L-arginine on mice placenta MA Al-Bayati, MA Ahmad, W Khamas Adv Pharmacoepidemiol Drug Saf 3 (150), 2167-1052.1000150, 2014 | 17 | 2014 |
| Towards new tools for pharmacoepidemiology B Robson Adv. Pharmacoepidemiol. Drug Saf. 1 (6), 1, 2013 | 17 | 2013 |
| Assessment of the survival status and risk factors for the mortality among multidrug resistant tuberculosis patients at Adama and Bishoftu general hospitals, Oromia, Ethiopia … D Fantaw, M Feyissa, S Hamid, W Shibeshi Adv Pharmacoepidemiol Drug Saf 7 (1), 2-5, 2018 | 16 | 2018 |
| Evaluation of antibiotic use in medical Ward of Fitche District hospital, north Showa zone, Oromia region, Ethiopia A Gube, R Gonfa, T Tadesse Adv Pharmacoepidemiol Drug Saf 6 (217), 2167-1052, 2017 | 15 | 2017 |
| Prevalence and pattern of potential drug-drug interactions in the critical care units of a tertiary hospital in Alexandria, Egypt S El Samia Mohamed, Z Gad, N El-Nimr, A Abdel Razek Adv Pharmacoepidemiol Drug Saf 2 (144), 2167-252, 2013 | 15 | 2013 |
| Pharmacovigilance programme of India: The beginning, current status and recent progress KNM Singh, HR Kanase Adv Pharmacoepidemiol Drug Saf 6 (4), 219, 2017 | 14 | 2017 |
| Medication safety in hospitals: avoiding medication errors in the medication use process NR Samaranayake, BMY Cheung Adv Pharmacoepidemiol Drug Saf 2, 1-7, 2013 | 14 | 2013 |
| Systematic approach to pharmacovigilance beyond the limits: the southern network on adverse reactions (SONAR) projects ZK Lu, SJ Kessler, R Schulz, J Bian, B Chen, J Wu Adv Pharmacoepidemiol Drug Saf 3 (2), 2014 | 13 | 2014 |
Amgad M. RabieLecturer & Researcher of Drug Discovery/Medicinal Chemistry & Clinical Medical ResearchVerified email at pharma.asu.edu.eg
